Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.20.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2020
Income Taxes [Abstract]  
Schedule of income before income taxes
Income before income taxes consisted of the following (in millions):
Year Ended December 31, 2020 2019 2018
United States $ 3,149  $ 3,249  $ 888 
International 6,600  7,537  7,337 
Total $ 9,749  $ 10,786  $ 8,225 
Schedule of income tax expense (benefit)
Income taxes consisted of the following (in millions):
United States State and Local International Total
2020        
Current $ 296  $ 396  $ 1,307  $ 1,999 
Deferred (220) 21  181  (18)
2019        
Current $ 508  $ 94  $ 1,479  $ 2,081 
Deferred (65) 52  (267) (280)
2018        
Current $ 591 
1
$ 145  $ 1,426  $ 2,162 
Deferred (386)
1
(81)
1
54 
1
(413)
1 Includes the tax impact that resulted from changes to our original provisional estimates of the impact of the Tax Reform Act as permitted by Staff Accounting Bulletin No. 118 ("SAB 118").
Reconciliation of the statutory U.S. federal tax rate and effective tax rates
A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows:
Year Ended December 31, 2020 2019 2018
Statutory U.S. federal tax rate 21.0  % 21.0  % 21.0  %
State and local income taxes — net of federal benefit 1.1  0.9  1.5 
Earnings in jurisdictions taxed at rates different from the statutory U.S.
federal tax rate
0.9 
1
1.1 
4,5,6
3.1 
8,9
Equity income or loss (1.4) (1.6) (2.5)
Tax Reform Act   —  0.1 
10
Excess tax benefits on stock-based compensation (0.8) (0.9) (1.3)
Other — net (0.5)
2,3
(3.8)
7
(0.6)
Effective tax rate 20.3  % 16.7  % 21.3  %
1 Includes net tax charges of $110 million (or a 1.1 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions, as well as other agreed-upon tax matters.
2 Includes net tax expense of $431 million (or a 4.4 percent impact on our effective tax rate) primarily related to changes in judgment on specific tax positions due to the Opinion and amounts required to be recorded for changes to other uncertain tax positions, including interest and penalties. Also includes a tax benefit of $107 million (or a 1.1 percent impact on our effective tax rate) related to changes in our assessment of certain valuation allowances and a net tax benefit of $135 million (or a 1.4 percent impact on our effective tax rate) related to domestic return to provision adjustments and other tax items.
3 Includes a tax benefit of $40 million (or a 2.4 percent impact on our effective tax rate) associated with the $902 million gain recorded upon the acquisition of the remaining ownership interest in fairlife. Refer to Note 2.
4 Includes net tax charges of $199 million (or a 1.9 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions, as well as other agreed-upon tax matters.
5 Includes the impact of pretax charges of $710 million (or a 1.2 percent impact on our effective tax rate) related to the impairment of certain of our equity method investees.
6 Includes a tax benefit of $199 million (or a 1.5 percent impact on our effective tax rate) recorded as a result of CCBA no longer qualifying as a discontinued operation. Refer to Note 2.
7 Includes a net tax benefit of $184 million (or a 1.7 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, a tax benefit of $145 million (or a 1.4 percent impact on our effective tax rate) related to changes in our assessment of certain valuation allowances and a net tax benefit of $89 million (or a 0.8 percent impact on our effective tax rate) related to domestic return to provision adjustments as well as other agreed-upon tax matters.
8 Includes the impact of pretax charges of $591 million (or a 1.5 percent impact on our effective tax rate) related to other-than-temporary impairments of certain of our equity method investees and the impact of a pretax charge of $554 million (or a 1.9 percent impact on our effective tax rate) related to an impairment of assets held by CCBA.
9 Includes net tax expense of $28 million on net pretax charges of $403 million (or a 1.4 percent impact on our effective tax rate) primarily related to the refranchising of certain foreign bottling operations.
10 Includes net tax expense of $8 million (or a 0.1 percent impact on our effective tax rate) related to the finalization of our accounting related to the Tax Reform Act.
Reconciliation of changes in the gross amount of unrecognized tax benefit
A reconciliation of the changes in the gross amount of unrecognized tax benefits is as follows (in millions):
Year Ended December 31, 2020 2019 2018
Balance of unrecognized tax benefits at beginning of year $ 392  $ 336  $ 331 
Increase related to prior period tax positions 528 
1
204 
2
11 
Decrease related to prior period tax positions (1) —  (2)
Increase related to current period tax positions 26  29  17 
Decrease related to settlements with taxing authorities (19) (174)
3
(4)
Increase (decrease) due to effect of foreign currency exchange rate changes (11) (3) (17)
Balance of unrecognized tax benefits at end of year $ 915  $ 392  $ 336 
1 The increase was primarily related to a change in judgment on certain tax positions due to the Opinion. Refer to Note 11.
2 The increase was primarily related to a change in judgment about the Company's tax positions with several foreign jurisdictions.
3 The decrease was primarily related to a change in judgment about one of the Company's tax positions that became certain as a result of settlement of a matter in the United States.
Deferred tax assets and liabilities
The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consisted of the following (in millions):
December 31, 2020 2019
Deferred tax assets:    
Property, plant and equipment $ 44  $ 53 
Trademarks and other intangible assets 2,214  2,267 
Equity method investments (including net foreign currency translation adjustments) 580  372 
Derivative financial instruments 523  389 
Other liabilities 1,401  1,066 
Benefit plans 893  880 
Net operating/capital loss carryforwards 320  259 
Other 391  311 
Gross deferred tax assets 6,366  5,597 
Valuation allowances (406) (303)
Total deferred tax assets $ 5,960  $ 5,294 
Deferred tax liabilities:    
Property, plant and equipment $ (837) $ (877)
Trademarks and other intangible assets (1,661) (1,533)
Equity method investments (including net foreign currency translation adjustments) (1,533) (1,667)
Derivative financial instruments (435) (348)
Other liabilities (402) (351)
Benefit plans (321) (286)
Other (144) (104)
Total deferred tax liabilities $ (5,333) $ (5,166)
Net deferred tax assets $ 627  $ 128 
Deferred tax asset valuation allowances
An analysis of our deferred tax asset valuation allowances is as follows (in millions):
Year Ended December 31, 2020 2019 2018
Balance at beginning of year $ 303  $ 419  $ 519 
Additions 240  148  83 
Deductions (137) (264) (183)
Balance at end of year $ 406  $ 303  $ 419